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ORIGINAL INVESTIGATION
Acute blood glucose fluctuation 
enhances rat aorta endothelial cell apoptosis, 
oxidative stress and pro-inflammatory cytokine 
expression in vivo
Na Wu1, Haitao Shen2, Henan Liu3, Yanjun Wang1, Yu Bai1 and Ping Han1* 
Abstract 
Background: Complications of diabetes mellitus (DM) are related not only to elevated plasma glucose, but also 
plasma glucose fluctuations. However, the specific mechanism underlying the role of plasma glucose fluctuation in 
the pathogenesis of DM complications remains poorly understood. In the present study, the influence of acute fluctu-
ant hyperglycemia and persistent hyperglycemia on vascular endothelial cell apoptosis, function, oxidative stress and 
inflammation was examined in vivo.
Methods: Rats were assigned to three different groups (n = 10/group) that received 48-h infusions of saline (SAL 
group), continuous 50 % glucose (constant high glucose group [CHG]), or intermittent 50 % glucose (acute blood 
glucose fluctuation group [AFG]). Plasma 8-isoprostaglandin, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and 
intercellular adhesion molecule-1 (ICAM-1) levels were quantified by using enzyme-linked immunosorbent assay 
(ELISA) commercial kits. Plasma insulin levels were measured by radioimmunoassays (RIAs) using kits. The aortic 
segment was collected. The levels of malondialdehyde (MDA) and activity of glutathione peroxidase (GSH-PX) were 
measured in endothelial homogenates prepared from endothelial cells harvested from the aorta using colorimetric 
kits. Apoptosis of vascular endothelial cells was determined with terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL). Endothelial dysfunction was assessed by isometric tension recording to evaluate the endothe-
lial function. The expression of B cell lymphoma-2 (Bcl-2), Bcl-2 Associated X protein (Bax), pro caspase-3, caspase-3 
p17, 3-nitrotyrosine (3-NT) and p47phox protein in rat aortic endothelial cells were tested with Western blot analysis. 
Endothelial cells reactive oxygen species (ROS) formation was determined using dihydroethidium-dependent fluores-
cence microtopography in aortic cryo-sections. Expression of IL-6, TNF-α and ICAM-1 mRNAs in vascular endothelial 
cells were determined by real-time quantitative PCR.
Results: Endothelial cells apoptosis and dysfunction were observed significantly in the aortas of the AFG group 
(P < 0.05). The AFG had reduced Bcl-2 and pro caspase-3 levels and enhanced Bax mitochondrial translocation and 
caspase-3 p17 protein levels in comparison with the CHG group (P < 0.05). Both AFG and CHG induced β-cell dys-
function and insulin resistance (P < 0.05). AFG increased MDA and 8-isoprostaglandin levels in plasma, oxidative stress 
in vascular endothelial cells, and inflammatory cytokines in plasma and vascular endothelial cells (P < 0.05).
Conclusion: Acute glucose fluctuation may cause significant oxidative stress and inflammation in endothelial cells, 
increase the adhesion of monocytes to endothelial cells, and elevate endothelial cell apoptosis, resulting in severe 
cardiovascular injury.
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Background
In recent years, studies have indicated that the occur-
rence and development of diabetes mellitus (DM) com-
plications are closely related to not only elevated plasma 
glucose (PG), but also fluctuations in PG [1]. Compared 
to persistent hyperglycemia, fluctuant hyperglycemia has 
more potential to increase microvascular lesions and the 
risk of cardiovascular death [2–4], but the specific mech-
anism is still unclear. Blood glucose fluctuation exists 
not only in diabetes, but also in individuals with normal 
metabolic function. In the condition of stress,the glu-
cose levels of those with normal metabolic function may 
be very high. In this case given hypoglycemic therapy, 
there may be glucose decreases sharply in the hypogly-
cemic process, leading to acute glucose fluctuations. We 
had successfully established acute blood glucose fluctua-
tion model before [5, 6]. Evidence indicates that oxida-
tive stress and inflammation are the major mechanisms 
underlying the pathogenesis of DM complications. The 
vicious cycle of oxidative stress and inflammation may 
damage cells, and increasing evidence suggests that acute 
PG fluctuation may induce oxidative stress in vivo [5].
Endothelial dysfunction is a key pathophysiological 
step in the early stage of vascular DM complications 
[7–9]. Previous studies have demonstrated that vascu-
lar dysfunction in the setting of diabetes is associated 
with increased vascular oxidative stress and low-grade 
inflammation [10–12]. Early in vitro studies showed that 
fluctuant hyperglycemia could increase the apoptosis 
of human umbilical vein endothelial cells [13, 14] and 
induce inflammation [15]. In recent years, in vitro stud-
ies have also indicated that fluctuant hyperglycemia may 
increase apoptosis, oxidative stress [16] and inflamma-
tion [17, 18] of human coronary artery endothelial cells 
(HCAECs). Mita et al. [19] demonstrated that swings in 
blood glucose levels accelerated atherogenesis in apolipo-
protein E-deficient mice. In Mita T’s study, apolipopro-
teine-deficient mice fed maltose twice daily were used as 
a model of repetitive postprandial glucose spikes, which 
simulated chronic hyperglycemia in  vivo. Blood glucose 
fluctuation exists not only in diabetes, but also in individ-
uals with normal metabolic function. In the condition of 
stress,the glucose levels of those with normal metabolic 
function may be very high. In this case given hypoglyce-
mic therapy, there may be glucose decreases sharply in 
the hypoglycemic process, leading to acute glucose fluc-
tuations. To date, few studies have been conducted to 
investigate the influence of acute fluctuant hyperglycemia 
on endothelial cells in  vivo. Our group had successfully 
established the acute fluctuant hyperglycemia animal 
model [5, 6], which was employed to investigate the 
effects of fluctuant hyperglycemia on endothelial cells.
In this study, glucose was intravenously injected into 
rats to establish animal models of acute fluctuant hyper-
glycemia and persistent hyperglycemia with the objective 
of exploring their influence on apoptosis, oxidative stress 
and inflammation of endothelial cells in vivo.
Methods
Animals
Normal male Wistar rats weighing 250–350  g (8–10   
weeks old) were provided by the Medical Animal Center, 
Shengjing Hospital of the China Medical University 
(Shenyang, China). The rats were subjected to a stand-
ard 12:12-h light–dark cycle and were given free access 
to regular chow and water. All animal experiments were 
performed with approval from the animal ethics com-
mittee of Shengjing Hospital of China Medical University 
(2016PS026 K). All experiments conformed to guidelines 
for ethical conduct in the care and use of animals. Every 
effort was made to minimize stress to the animals.
Animal surgeries
Indwelling catheters (PE-50; Cay Adams, Boston, MA, 
USA), each extended with a 3-cm segment of silastic tub-
ing with an internal diameter 0.02 in (Care Express Prod-
ucts, Inc., Cary, IL, USA), were inserted into the internal 
jugular vein of the rats for infusion and the carotid artery 
for blood sampling as described previously [20]. After 
surgery, the rats had 3–4 days of recovery before intrave-
nous infusion.
Intravenous infusions
Food was withdrawn 12–14 h before each infusion. The 
rats were assigned to three different groups (n  =  10/
group), each of which underwent 48-h infusions with (1) 
saline (5.5 mL/min; SAL group); (2) continual 50 % glu-
cose (blood glucose was monitored regularly to keep the 
glucose concentration at 20 ± 0.5 mmol/l, constant high 
glucose [CHG] group); or (3) intermittent 50  % glucose 
(Every 15 min, we measured the blood glucose level, and 
adjusted the glucose infusion rate according to the blood 
glucose monitoring. The blood glucose level alternated 
between 5.5 ± 0.5 and 20 ± 0.5 mmol/L. That is to say, 
control the glucose level at about 5.5 mmol/l for 1 h, and 
then at 20 mmol/l for 1 h, so the cycle. Acute blood glu-
cose fluctuation [AFG] group) (Fig.  1). The procedures 
for infusion were followed as previously described [5].
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Plasma assays
Glucose concentrations in plasma were measured with 
a Beckman Glucose Analyzer II (Beckman, Fullerton, 
Calif., USA). At the beginning and the end of the 48  h 
infusion, plasma insulin levels were measured by radio-
immunoassays (RIAs) using kits specific for rat (Beijing 
Furui Biological Engineering Co, China). With plasma 
insulin and glucose levels, insulin resistance was esti-
mated as homeostasis model of assessment for insulin 
resistence index (HOMA-IR) using HOMA Calculator 
v2.2.3 offered by University of Oxford. Insulin secre-
tion (β cell function) was obtained as HOMA-β % using 
HOMA Calculator. Circulating oxidative stress, meas-
ured as the plasma concentration of 8-isoprostaglandin, 
was analyzed using an enzyme-linked immunosorbent 
assay (ELISA) commercial kits (Uscnlife, Missouri, TX, 
USA). The plasma levels of malondialdehyde (MDA) were 
measured using colorimetric kits (Nanjing Jiancheng 
Institute of Bio-engineering, China). Plasma interleu-
kin-6 (IL-6), tumor necrosis factor-α (TNF-α) and inter-
cellular adhesion molecule-1 (ICAM-1) levels were 
quantified by using commercially available ELISA kits 
(Uscnlife, Missouri, TX, USA), according to the manufac-
turer’s instructions.
Tissue collection and preparation of endothelial cell 
homogenates
After 48  h of infusion, rats were anesthetized with an 
intraperitoneal injection of chloral hydrate (400  mg/
kg). After blood collection, the animals were perfused 
with 100  mL of normal saline. Then, an aortic segment 
was collected to detect apoptosis, reactive oxygen spe-
cies (ROS) formation and vascular function. Another 
aortic segment was collected, and vascular endothelial 
cells were harvested followed by extraction of protein 
for western blotting assay. The procedures for endothe-
lial cell homogenate sample preparation were followed as 
previously described [21]. Briefly, after opening the aorta 
longitudinally and rinsing it with PBS, the inner surface 
was gently scraped with the tip of a scalpel to selec-
tively isolate endothelial cells. The endothelial scrapings 
from each rat aorta were sonicated in 200 μl of ice-cold 
homogenizing buffer. The aortic endothelial homogenate 
was clarified by centrifugation (13,800×g for 10  min at 
4 °C), snap-frozen and stored at −80 °C for Western blot 
analysis. Protein concentrations were determined by the 
Coomassie brilliant blue G-250 dye-binding method.
Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay
Paraffin-embedded aorta sections were processed for a 
terminal deoxynucleotidyl transferase dUTP nick end 
labeling assay with kits from Roche Company (Man-
nheim,  Germany) according to the manufacturer’s 
instructions. Sections were deparaffinized and rehy-
drated. After washing with PBS three times, all sections 
were incubated for 8 min in freshly prepared 0.1 % Triton 
X-100 permeabilization solution with 0.1 % citrate buffer 
and then washed with PBS. A TUNEL TdT enzyme reac-
tion mixture (50 µL) was added to each sample and incu-
bated for 1 h in a humidifying chamber at 37  °C. Slides 
were then washed and observed under a fluorescence 
microscope.
Endothelial function studies
We detected acetylcholine (Ach)-dependent vasodila-
tation by isometric tension recording to evaluate the 
endothelial function. Vasodilator responses to the 
endothelium-dependent vasodilator Ach were assessed 
in organ chambers by isometric tension studies, precon-
stricted with phenylephrine (PheE), as described previ-
ously, as previously described [22].
Western blot analysis of B‑cell lymphoma‑2 (Bcl‑2), Bcl‑2 
associated X protein (Bax), pro caspase‑3, caspase‑3 p17, 
3‑nitrotyrosine (3‑NT) and p47phox protein expression
Endothelial cell homogenates containing equal amounts 
of protein were separated using SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) and were transferred onto 
polyvinylidene fluoride (PVDF) membranes. To inves-
tigate the membrane association of soluble NADPH-
oxidase subunits p47phox, the lysates were separated 
into cytosolic and membrane fractions by ultracentrifu-
gation (100,000×g for 1 h at 4 °C). The membranes were 
Fig. 1 Acute blood glucose fluctuation model. Blood glucose alternated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l
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blocked in Tris-buffered saline-Tween (TBST) containing 
5 % non-fat dried milk (pH 7.4) for 2 h at room temper-
ature and then incubated with one of the following pri-
mary antibodies: monoclonal mouse Bax (1:200, Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), monoclonal 
mouse Bcl-2 (1:1000, Santa Cruz Biotechnology), mono-
clonal mouse caspase-3 (1:200, Santa Cruz Biotechnol-
ogy), polyclonal goat caspase-3 p17, 1:1000, Santa Cruz 
Biotechnology), 3-NT (1:1400, Abcam, Cambridge, MA, 
USA),monoclonal mouse p47phox(1:500, Santa Cruz 
Biotechnology), monoclonal mouse GAPDH (1:5000, 
Abcam), monoclonal mouse COX-IV (1 μg/ml, Abcam), 
monoclonal rabbit Na/K ATPase (1:100000, Abcam) and 
monoclonal mouse β-actin (1:1000, Santa Cruz Biotech-
nology). After the membranes were washed with TBST, 
incubated with a horseradish peroxidase-conjugated sec-
ondary antibody for 2 h at room temperature, the bands 
were exposed using an enhanced chemiluminescence 
(ECL) kit (Pierce Biotechnology, Rockford, IL, USA). Pro-
tein bands were visualized using ChemDocTM XRS with 
Quantity OneTM software (BioRad, Hercules, CA, USA). 
Blots were repeated at least three times for every condi-
tion. After development, the band intensities were quan-
tified using Image-pro Plus 6.0 analysis software. The 
relative protein levels were calculated based on β-actin or 
GAPDH or Na/K ATPase as the loading control.
MDA level, glutathione peroxidase (GSH‑PX) activity 
and ROS formation analysis
The levels of MDA and activity of GSH-PX in the 
endothelial cells were measured using colorimetric 
kits (Nanjing Jiancheng Institute of Bio-engineering, 
Nanjing, China). Endothelial cells ROS formation was 
determined using dihydroethidium (DHE, Santa Cruz 
Biotechnology)-dependent fluorescence microtopog-
raphy in aortic cryo-sections. Briefly, the sections were 
immersed in 10  μmol/L dihydroethidium (in PBS solu-
tion) in a humidified environment at room temperature 
for 30 min. Dihydroethidium is oxidized by superoxide to 
form ethidium, which binds to DNA in the nucleus and 
emits red fluorescence. After washing with PBS three 
times, the sections were cover-slipped and then visual-
ized under a fluorescence microscope (BX41, Olympus, 
Tokyo, Japan). Intensity of the DHE oxidation products’ 
fluorescence was evaluated by densitometry.
Real‑time quantitative PCR analysis
Total RNA was extracted from the endothelial cell 
homogenates with TRIzol Reagent (Takara, Shiga, Japan). 
The quantity and quality of the total RNA were deter-
mined by spectrophotometry. Then, 1  µg of total RNA 
was reverse-transcribed to cDNA using the Reverse 
Transcription System (Takara). Quantitative PCR analysis 
was carried out using an ABI Prism 7500 Sequence Detec-
tion System (Applied Biosystems, Foster City, CA, USA) 
with SYBR green PCR reagents (Takara). The primers for 
IL-6, TNF-α, ICAM-1 and β-actin were as follows: IL-6 
(sense 5′-TCGAGCCCACCGGGAACGAA-3′; antisense 
5′-GCAACTGGACCGAAGGCGCT-3′); TNF-α (sense 
5′-CGAGTCTGGGCAGGTCTACTTT-3′; antisense 5′-A 
GAGGTTGAGGGTGTCTGAAGG-3′); ICAM-1 (sense 
5′-CCTTCCTCACCGTGTACTGG-3′; antisense 5′-AG 
CGTAGGGTAAGGTTCTTGC-3′); β-actin (sense 5′-GG 
AGATTACTGCCCTGGCTCCTA; antisense 5′-GACTC 
ATCGTACTCCTGCTTGCTG). Relative expression was 
normalized with β-actin.
Statistical analysis
Data are expressed as mean ±  standard deviation (SD). 
One-way analysis of variance (ANOVA) with a Tuk-
ey’s post hoc test was performed to detect differences 
between the groups. Analyses of all data were performed 
using the SPSS software (version 13.0; SPSS, Chicago, IL, 
USA). P < 0.05 were considered statistically significant.
Results
An acute blood glucose fluctuation model was successfully 
established
In the AFG group, PG fluctuated between 5.5 and 
20 mmol/L. PG was maintained at 5.5 mmol/L for about 
1 h and then at 20 mmol/L for another 1 h over a period 
of 48 h (Fig. 1).
Insulin secretion and insulin resistance
At the end of the 48 h infusion, insulin levels were sig-
nificantly increased in the AFG and CHG groups in 
comparison with the SAL group (P  <  0.05; Fig.  2a). 
The AFG group had higher insulin levels than the 
CHG group, but the difference was not statistically 
significant (P  >  0.05; Fig.  2a). Insulin resistance, esti-
mated as HOMA-IR, was higher in the AFG and CHG 
groups than that in the SAL group (P < 0.05; Fig. 2b). In 
contrast,β cell function, estimated as HOMA-β  % was 
lower in the AFG and CHG groups than that in the SAL 
group (P < 0.05; Fig. 2c). But neither the HOMA-IR nor 
HOMA-β  % showed significant difference between the 
AFG and CHG group.
Apoptosis of vascular endothelial cells
The apoptosis of aorta vascular endothelial cells was 
detected using the TUNEL assay. In the AFG group, the 
apoptosis index was higher than the other two groups. 
But there is no differences between SAL and CHG group 
(Fig. 3).
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Endothelial function
As shown in Fig. 4, AFG caused endothelial dysfunction 
which resulted in a significant right-shift of the acetyl-
choline concentration–relaxation curve as observed by 
isometric tension studies (P < 0.05). Vasodilator potency 
and efficacy were shown in Table  1. Potency is −log 
EC50 and EC50 is the concentration that induces half-
maximal relaxation with respect to the maximal relaxa-
tion achieved with the highest concentration of the 
vasodilator used. Efficacy is defined as maximal relaxa-
tion obtained with the highest concentration of the vas-
odilator used. Endothelial function in the CHG group is 
worse than in the CHG group, but the difference was not 
statistically significant (P < 0.05; Fig. 4; Table 1).
Expression of Bax, Bcl‑2, pro caspase‑3 and caspase‑3 p17 
proteins
As shown in Fig.  5, total Bax, mitochondrial Bax and 
caspase-3 p17 protein levels in the CHG and AFG group 
were all significantly increased compared with the SAL 
group (P < 0.05; Fig. 5a, b, d). Furthermore, the expres-
sion of total Bax, mitochondrial Bax and caspase-3 p17 
in the AFG group was higher than that in the CHG group 
(P  <  0.05; Fig.  5a, b, d). In addition, both constant high 
glucose and acute blood glucose fluctuation decreased 
the levels of Bcl-2 and pro caspase-3 protein when com-
pared with the SAL group, and the AFG group had sig-
nificantly reduced Bcl-2 and pro caspase-3 levels in 
comparison with the CHG group (both P < 0.05; Fig. 5c, 
d respectively).
Circulating 8‑isoprostaglandin and MDA levels
Circulating oxidative stress in this study was measured as 
the concentration of 8-isoprostaglandin and MDA. 8-iso-
prostaglandin is an in vivo oxidative stress marker, which 
is produced in a non-cyclooxygenase-dependent manner 
involving lipid peroxidation [23]. MDA, a marker of lipid 
peroxidation, was also measured. As shown in Fig.  6c 
and d, plasma 8-isoprostaglandin and MDA levels were 
significantly increased in the AFG and CHG groups in 
comparison with the SAL group (P < 0.05). The levels of 
these two oxidative stress markers were also significantly 
higher in the AFG group than those in the CHG group 
(P < 0.05; Fig. 6c, d respectively).
Fig. 2 Insulin secretion and insulin resistance. a Plasma insulin levels at the beginning and the end of the infusion. b Insulin resistance was esti-
mated as HOMA-IR. c β cell function was estimated as HOMA-β %. SAL (SAL group rats underwent 48 h infusions with saline); CHG (CHG group rats 
underwent 48 h infusions with 50 % glucose continually to keep the glucose concentration at 20 ± 0.5 mmol/l); AFG (AFG group rats underwent 
48 h infusions with 50 % glucose intermittently so that blood glucose alternated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). Data are mean ± SD. 
n = 10/group. *P < 0.05 vs SAL
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P47phox and 3‑NT protein levels, MDA levels, GSH‑PX 
activities, and ROS formation in vascular endothelial cells
As shown in Fig.  6a, 3-NT protein levels in the CHG 
and AFG group were significantly increased compared 
with the SAL group, and the levels in the AFG group 
were higher than that in the CHG group (P  <  0.05; 
Fig. 6a). Both the cytosolic and the membrane p47phox 
levels in the CHG and AFG group were significantly 
increased compared with the SAL group. Most impor-
tantly, the ratio of membrane-bound to cytosolic portion 
of p47phox was also increased in high glucose groups. 
In addition, the ratio was higher in the AFG group than 
that in the CHG group (P < 0.05; Fig. 6b). As shown in 
Fig. 6e, the MDA levels in vascular endothelial cells were 
significantly increased in the AFG and CHG groups as 
compared with the SAL group (P  <  0.05). Moreover, 
the AFG group had higher MDA levels than the CHG 
group (P  <  0.05). On the contrary, the GSH-PX activi-
ties in vascular endothelial cells were decreased in the 
fluctuating condition compared with rats exposed to 
continually high glucose (P < 0.05, Fig. 6f ). Furthermore, 
the GSH-PX activities in the CHG and AFG groups were 
lower than that of the SAL group (P < 0.05, Fig. 6f ). Aor-
tic ROS formation was detected in cryo-sections using 
DHE dependent fluorescent micro-topography (Fig. 6g), 
which was quantified by densitometry. Densitometric 
quantification of the DHE-derived ROS signal in the 
endothelium of vessels was shown in Fig. 4h. There was 
a significant increase in ROS formation in the endothe-
lium of vessels from the CHG and AFG rats. And the 
levels of ROS formation were significantly higher in 
the AFG group than those in the CHG group (P < 0.05; 
Fig. 6h).
Plasma inflammatory cytokine concentrations
The circulating levels of IL-6, TNF-α, and ICAM-1 
increased significantly in the CHG and AFG groups com-
pared with the SAL group (P < 0.05, Fig. 7). In addition, 
the concentrations in the AFG group were higher than 
that of the CHG group (P < 0.05, Fig. 7).
Fig. 3 Apoptosis of vascular endothelial cells. TUNEL: bodies were stained with FITC-12-dUTP; DAPI: cell nucleus were stained with DAPI; 
merged:merge two pictures before. The red arrow showed the apoptotic endothelial cells. SAL (SAL group rats underwent 48 h infusions with 
saline); CHG (CHG group rats underwent 48 h infusions with 50 % glucose continually to keep the glucose concentration at 20 ± 0.5 mmol/l); 
AFG (AFG group rats underwent 48 h infusions with 50 % glucose intermittently so that blood glucose alternated between 5.5 ± 0.5 and 
20 ± 0.5 mmol/l). Data are mean ± SD. n = 10/group. *P < 0.05 vs SAL; #P < 0.05 vs CHG
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IL‑6, TNF‑α and ICAM‑1 mRNA expression in vascular 
endothelial cells
In the CHG and AFG groups, IL-6, TNF-α and ICAM-1 
mRNA expression was significantly higher than the SAL 
group (P < 0.05, Fig. 8). The mRNA expression of all three 
cytokines was significantly higher in the AFG group com-
pared to the CHG group (P < 0.05, Fig. 8).
Discussion
The incidence of cardiovascular diseases in DM patients 
is significantly higher than in non-DM patients [24]. Vas-
cular endothelial cell injury and dysfunction are impor-
tant pathophysiological events in the occurrence and 
development of DM complications and cardiovascular 
events. Masaru Kuroda’s study reported that compared 
with a marker of averaged blood glucose level such as 
HbA1c, mean amplitude of glycemic excursions (MAGE) 
was a more contributing factor of vascular injury [25]. 
Increasing evidence shows that fluctuant hyperglyce-
mia is more harmful for the heart and vessels compared 
to persistent hyperglycemia [3, 26], but the specific 
mechanism remains poorly understood. Previous stud-
ies have focused on the influence of PG fluctuation on 
endothelial cells in  vitro [13, 16, 18, 27, 28]; however, 
few in vivo studies have been conducted. In the present 
study, an in vivo model of acute fluctuant hyperglycemia 
was successfully established. In vivo and in vitro experi-
ments  have confirmed  the effects of continual or inter-
mittent high glucose on endothelial cells are unrelated 
to the hyperosmotic condition [13, 29]. In A. RISSO’s 
study [13], Osmotic control was assured by incubating 
endothelial cells with 20 mmol/l mannitol, both continu-
ously or in alternating fashion. Nonspecific effects due to 
osmolarity changes had be ruled out, because the cyto-
toxic effect was not detected in the cells cultured in the 
presence of 20  mmol/l mannitol, either continuously or 
in alternating fashion. It demonstrated that the effects 
of continual or intermittent high glucose are unrelated 
to the hyperosmotic condition. Our results showed 
that the 48  h persistent hyperglycemia did not cause 
apoptosis and dysfunction of vascular endothelial cells 
in  vivo,while acute fluctuant hyperglycemia caused sig-
nificantly apoptosis. But the Mechanism is not clear, the 
endothelial cell apoptosis and dysfunction are likely due 
to oxidative stress and inflammation effects,but may also 
be secondary to insulin resistance or β-cell dysfunction, 
and so on. In this study, both the AFG and CHG groups 
induced insulin resistance, and decreased the β-cell func-
tion. However, we observed that neither the HOMA-IR 
or HOMA-β % showed significant difference between the 
AFG and CHG group. Moreover, acute fluctuant hyper-
glycemia could significantly increase oxidative stress and 
inflammation of vascular endothelial cells in  vivo com-
pared to persistent hyperglycemia. So we speculated that, 
the endothelial cell apoptosis and injury are mainly asso-
ciated with oxidative stress and inflammatory effects.
Although the impact of hyperglycemia on increasing 
the oxidative stress of endothelial cells has been con-
firmed [3, 30–32], few studies have compared the effects 
of intermittent and chronic hyperglycemia on vascular 
endothelial cell oxidative stress in  vivo. Oxidative stress 
refers to the production of ROS, overwhelming their 
clearance and leading to their accumulation. A variety of 
pathological factors may cause excess production of ROS 
or reduced clearance of ROS, which disrupts the balance 
between oxidation and anti-oxidation, increases ROS 
in the blood and finally results in a oxidative status [33, 
Fig. 4 Endothelium-dependent vascular relaxation by the vaso-
dilators acetylcholine (ACh). SAL (SAL group rats underwent 48 h 
infusions with saline); CHG (CHG group rats underwent 48 h infusions 
with 50 % glucose continually to keep the glucose concentration 
at 20 ± 0.5 mmol/l); AFG (AFG group rats underwent 48 h infusions 
with 50 % glucose intermittently so that blood glucose alternated 
between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). Data are mean ± SD. 
n = 10/group
Table 1 Potencies and  efficacies of  the endothelium-
dependent vasodilator acetylcholine (Ach) in rat aorta
SAL (SAL group rats underwent 48 h infusions with saline); CHG (CHG group rats 
underwent 48 h infusions with 50 % glucose continually to keep the glucose 
concentration at 20 ± 0.5 mmol/l); AFG (AFG group rats underwent 48 h 
infusions with 50 % glucose intermittently so that blood glucose alternated 
between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). Data are mean ± SD. n = 10/group. 
* P < 0.05 vs SAL
Parameter SAL CHG AFG
Ach potency (−log EC50) 7.9 ± 0.05 7.8 ± 0.06 7.2 ± 0.08*
Ach efficacy (max, relaxation, %) 98 ± 1.2 96 ± 2.4 75 ± 1.8*
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34]. Evidence indicates that oxidative stress is a major 
mechanism of vascular endothelial dysfunction, and ROS 
production increased significantly in persistent hypergly-
cemia, accompanied by reduced antioxidase activity, sug-
gesting compromised anti-oxidative activity [3, 30–32]. 
In vitro studies show that fluctuant hyperglycemia may 
increase oxidative stress of human coronary endothelial 
cells [16]. Monnier et  al. [3] found fluctuant hypergly-
cemia could also increase oxidative stress in the human 
body. P47phox is a cytosolic component of the NADPH 
oxidase, which could be activated or inactivated by the 
extra signal, thus to be the main enzyme responsible for 
ROS production. [22]. 3-NT is considered as a marker 
of peroxynitrite-mediated oxidative stress, which occurs 
during inflammation. MDA is a classic biomarker of oxi-
dative stress and an aldehyde secondary to ROS-induced 
lipid peroxidation; its level may reflect the severity of 
oxidative stress and also may serve as an important path-
ological indicator [35]. GSH-PX is an important anti-
oxidase, and the content and activity of GSH-PX may 
directly affect the concentration of ROS in cells [36]. Fur-
thermore, plasma 8-isoprostaglandin represents a useful 
in vivo oxidative stress marker [23]. In the present study, 
acute fluctuant hyperglycemia dramatically increased the 
3-NT expression,the MDA content,the ratio of mem-
brane-bound to cytosolic portion of p47phox,and the 
ROS formation, while GSH-PX activity was reduced sig-
nificantly, suggesting that oxidative stress is a major cause 
of endothelial injury. Furthermore, acute fluctuant hyper-
glycemia had a more potent capability to induce oxidative 
stress as compared to persistent hyperglycemia, which is 
consistent with previous findings [16].
Studies have shown that hyperglycemia may induce 
apoptosis of vascular endothelial cells in  vitro [13, 16, 
Fig. 5 Western blot analysis of Bax, Bcl-2, pro caspase-3 and caspase-3 p17 proteins in vascular endothelial cells. a Total bax protein expression in 
vascular endothelial cells. b Mitochondrial Bax protein expression in vascular endothelial cells. c Bcl-2 expression in vascular endothelial cells. d Pro 
caspase-3 and caspase-3 p17 expression in vascular endothelial cells. SAL (SAL group rats underwent 48 h infusions with saline); CHG (CHG group 
rats underwent 48 h infusions with 50 % glucose continually to keep the glucose concentration at 20 ± 0.5 mmol/l); AFG (AFG group rats under-
went 48 h infusions with 50 % glucose intermittently so that blood glucose alternated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). β-Actin antibodies 
were used as loading controls. A representative western blot is shown. Data are mean ± SD. n = 10/group. *P < 0.05 vs SAL; #P < 0.05 vs CHG
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37–41]. In addition, transient fluctuant PG may also 
induce apoptosis of vascular endothelial cells, and more 
endothelial cells became apoptotic after fluctuant hyper-
glycemia than after persistent hyperglycemia [13, 14, 16, 
39]. However, few studies have been conducted to inves-
tigate the influence of acute fluctuant hyperglycemia on 
apoptosis of endothelial cells in vivo. In the present study, 
acute fluctuant hyperglycemia significantly increased the 
number of apoptotic rat vascular endothelial cells and 
induced endothelial dysfunction; however, endothelial cell 
apoptosis and dysfunction was absent following persistent 
hyperglycemia. Furthermore, we detected the expression 
of the apoptosis-related proteins, Bax,Bcl-2, pro caspase-3 
and caspase-3 p17, in endothelial cells. Bcl-2 and Bax are 
Fig. 6 Oxidative stress markers in plasma and vascular endothelial cells. a 3-nitrotyrosine (3-NT) expression in vascular endothelial cells. b P47phox 
expression in vascular endothelial cells. c 8-isoprostaglandin levels in plasma. d Malondialdehyde (MDA) levels in plasma. e MDA levels in vascular 
endothelial cells. f Glutathione peroxidase (GSH-PX) activities in vascular endothelial cells. SAL (SAL group rats underwent 48 h infusions with saline); 
g Dihydroethidium (DHE)-fluorescence microtopography was used to assess the effects of glucose treatment on aortic reactive oxygen species 
(ROS) production. Representative microscope images are shown. Red fluorescence indicates ROS formation whereas green fluorescence represents 
basal laminae autofluorescence. h Densitometric quantification of the DHE-derived ROS signal in the endothelium of vessels. CHG (CHG group rats 
underwent 48 h infusions with 50 % glucose continually to keep the glucose concentration at 20 ± 0.5 mmol/l); AFG (AFG group rats underwent 
48 h infusions with 50 % glucose intermittently so that blood glucose alternated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). Data are mean ± SD. 
n = 10/group. *P < 0.05 vs SAL; #P < 0.05 vs CHG
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the most important pair of proteins with opposite func-
tions [42]. Mitochondrial translocation of Bax increases 
mitochondrial membrane permeability and conse-
quently favors the release of apoptogenic factors, such as 
cytochrome C, leading to the expression of caspase 3 [43]. 
Caspase-3 is a crucial executive protease in the process of 
apoptosis [44]. Our results demonstrated that persistent 
hyperglycemia and fluctuant hyperglycemia significantly 
increased the expression of Bax protein and promoted its 
translocation to the outer mitochondrial membrane, and 
markedly reduced Bcl-2 protein expression, which was 
accompanied by elevated expression of caspase-3 p17. Of 
note, as compared to persistent hyperglycemia, fluctuant 
hyperglycemia increased Bax translocation to mitochon-
dria and caspase-3 p17 expression and reduced Bcl-2 
expression to greater levels. Taken together, both acute 
fluctuant hyperglycemia and persistent hyperglycemia 
may initiate the apoptosis and dysfunction of endothelial 
cells, but persistent hyperglycemia failed to significantly 
induce endothelial apoptosis and dysfunction, which 
might be ascribed to the short-term exposure to hyper-
glycemia used in this study. Thus, we speculate that acute 
fluctuant hyperglycemia is more harmful to endothelial 
cells than persistent hyperglycemia.
There is a growing body of evidence for the complex 
involvement of inflammation in DM and its resultant 
Fig. 7 ELISA analysis of IL-6, TNF-α and ICAM-1 in plasma. a The Circulating levels of Interleukin-6 (IL-6). b The Circulating levels of Tumor necrosis 
factor-α (TNF-α). c The Circulating levels of Intercellular adhesion molecule-1(ICAM-1). SAL (SAL group rats underwent 48 h infusions with saline); 
CHG (CHG group rats underwent 48 h infusions with 50 % glucose continually to keep the glucose concentration at 20 ± 0.5 mmol/l); AFG (AFG 
group rats underwent 48 h infusions with 50 % glucose intermittently so that blood glucose alternated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). 
Data are mean ± SD. n = 10/group. *P < 0.05 vs SAL; #P < 0.05 vs CHG
Fig. 8 Expression of IL-6, TNF-α and ICAM-1 mRNAs in vascular endothelial cells. a The mRNA expressions of Interleukin-6 (IL-6) in vascular endothe-
lial cells. b The mRNA expressions of tumor necrosis factor-α (TNF-α) in vascular endothelial cells. c The mRNA expressions of intercellular adhesion 
molecule-1(ICAM-1) in vascular endothelial cells.CHG (CHG group rats underwent 48 h infusions with 50 % glucose continually to keep the glucose 
concentration at 20 ± 0.5 mmol/l); AFG (AFG group rats underwent 48 h infusions with 50 % glucose intermittently so that blood glucose alter-
nated between 5.5 ± 0.5 and 20 ± 0.5 mmol/l). Data are mean ± SD. n = 10/group. *P < 0.05 vs SAL; #P < 0.05 vs CHG
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cardiovascular complications [18]. Prabhakaran Kumar 
et al. [45] demonstrated that high glucose could regulate 
the expression of IL-6 and IL-17 family cytokines tran-
scriptionally through oxidative stress and NF-κB activa-
tion via PKC and p38 MAPK signaling pathways. Finally, 
high glucose also increases the adhesion of lympho-
cytes to endothelial surfaces and thereby promoting the 
pathogenesis of atherosclerosis [45]. Pro-inflammatory 
cytokines, such as IL-6 and TNF-α, play important roles 
in the occurrence and development of vascular athero-
sclerosis [46–48]. It has also been widely accepted that the 
adhesion of monocytes and macrophages to endothelial 
cells is crucial for the pathogenesis of atherosclerosis [49]. 
ICAM-1 is an important adhesion molecule, mediating 
intercellular adhesion. In vascular endothelial cells, basal 
ICAM-1 expression is at a low level. ICAM-1 may bind 
to the specific receptor on vascular endothelial cells to 
exert its biological effects. In studies using umbilical vein 
endothelial cells, fluctuant hyperglycemia could signifi-
cantly increase the content of IL-6, TNF-α and ICAM-1 
in vitro [15, 17, 18, 50]. Esposito et al. [51] also found that 
fluctuant hyperglycemia could induce TNF-α produc-
tion in the blood of human in vivo. Previous study have 
shown that high glucose altered the expression profile of 
cytokines/chemokines via specific signaling pathways and 
can increase monocyte-endothelial adhesion in mono-
cytes [52]. In our study, an acute increase in PG could 
increase the plasma levels of IL-6, TNF-α and ICAM-1 
and their expression by vascular endothelial cells, and 
greater inductions were observed following exposure to 
fluctuant hyperglycemia. Thus, for the first time, our study 
indicates that acute fluctuant hyperglycemia has a more 
potent ability to increase pro-inflammatory cytokines 
production in vivo as compared to persistent hyperglyce-
mia, which is consistent with previous studies in vitro [15, 
17, 18, 50]. In summary, our results indicate that acute 
fluctuant hyperglycemia is likely to induce more severe 
inflammation and may be more harmful to the cardiovas-
cular system as compared to persistent hyperglycemia.
Conclusion
Taken together, our results confirm that fluctuant hyper-
glycemia may significantly increase oxidative stress and 
inflammation in endothelial cells, elevate the adhesion of 
monocytes to endothelial cells, increase endothelial cell 
apoptosis and dysfunction, and cause more severe cardi-
ovascular injury in vivo. It suggests that glucose fluctua-
tion could have a more ominous impact on the function 
of endothelial cells to promote atherosclerosis. Therefore, 
not only lowering blood glucose, but also reducing glu-
cose fluctuation is very important in clinic. Based on the 
control of blood glucose fluctuation, anti-oxidative and 
anti-inflammatory therapies may provide an alternative 
for the treatment of fluctuant hyperglycemia-induced 
cardiovascular diseases.
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